Promega announced recently that it has launched a wastewater testing kit that pairs its Maxwell HT chemistry with Ceres Nanosciences’ Nanotrap particles, an established technology for capturing and concentrating low-abundance…
Promega is launching a post-doctoral research program for life science researchers to explore new ideas for genome engineering technology, the company announced today. AstraZeneca will provide mentoring support in the three-year…
Promega and FUJIFILM Cellular Dynamics Inc. announced recently that they will partner to advance novel assay development for drug discovery. According to a release, the multi-year licensing agreement will integrate…
Promega has opened the Kornberg Center, its newly constructed research and development facility, the company announced today. According to a release, the three-story, 280,000-square-foot building will support core product and technology…
The Promega Wellness Center, a healthcare facility for employees on the company’s Fitchburg, Wis., campus, is now a state-approved COVID-19 vaccination site, the company announced today. “Public-private partnerships are critical…
Promega surpassed its environmental improvement goals set for the end of 2020 and achieved reductions in key sustainability metrics, according to its newly released Corporate Responsibility Report, the company announced…
Promega’s Maxwell RNA Extraction System has been authorized for use in the CDC’s COVID-19 diagnostic testing protocol, the company announced today. The FDA granted the authorization on Monday. “This announcement…
Promega announced recently that its custom manufacturing is being recognized for supporting the rapid development of a Utah-based company’s new coronavirus test that received CE mark approval earlier this week. According…
Promega announced today that it will develop its microsatellite instability (MSI) technology for Merck. According to a release, MSI technology may be used to better characterize tumors and guide therapeutic choices for…
Promega has partnered with BioIVT, a provider of research models and services for drug and diagnostic development, the company announced today. According to a release, BioIVT will offer Promega Immune…
